A drug billed by Sanofi as a successor to its blockbuster inflammation and immunology blockbuster Dupixent is being prepared for phase 3 trials in asthma – even though it missed the mark in a midstage ...

New Delhi: A new pill has shown promise against antibiotic-resistant gonorrhoea -- a common sexually transmitted infection (STI) --, according to a study published in the journal The Lancet.

As we’ve been reporting, US Vice-President JD Vance says there is a “good chance” that the US and UK will come to a mutually beneficial trade agreement, in comments released overnight. He told news ...